David M. Smadja

Artificial intelligence shaping the future of adipose-derived therapies in regenerative medicine

Haizam Oubari, David M. Smadja, Ali M Mojallal, Alexandre G. Lellouch

This letter comments on the recent review by Gandolfi et al. on adipose tissue-derived therapies, commending their comprehensive overview while expanding the discussion to emphasize the transformative role of artificial intelligence (AI). We highlight how AI integrates multi-omics datasets to reveal molecular …

us, fr (code pays fourni par la source)

TransEndocardial Injection of Autologous Expanded CD34+ Stem Cells (ProtheraCytes®) after myocardial infarction: Impact on Patients’ Quality of Life

Jerome G. Roncalli, François Roubille, Philippe Henon, Pierre-Yves Marie et autres

fr, us (code pays fourni par la source)

Image cytometry differentiates CD34 + and CD133 + profiles of very small embryonic-like stem cells

David M. Smadja, Anna Chipont, Léa Guyonnet, Alexandre G. Lellouch et autres

Very small embryonic-like stem cells (VSELs) have been identified as potential precursors of the endothelial lineage in humans. Traditionally characterized by CD34 and CD133 markers, these populations remain poorly delineated, particularly regarding their morphological traits. Leveraging recent advances in imaging flow cytometry …

fr, us (code pays fourni par la source)